Eagle Asset Management Inc. Decreases Position in Teladoc Health Inc (NYSE:TDOC)

Eagle Asset Management Inc. lessened its holdings in Teladoc Health Inc (NYSE:TDOC) by 0.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,011,214 shares of the health services provider’s stock after selling 2,859 shares during the period. Eagle Asset Management Inc. owned approximately 1.40% of Teladoc Health worth $68,479,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. CENTRAL TRUST Co lifted its position in shares of Teladoc Health by 82.6% during the 2nd quarter. CENTRAL TRUST Co now owns 378 shares of the health services provider’s stock worth $27,000 after purchasing an additional 171 shares during the last quarter. Meridian Wealth Management LLC purchased a new stake in shares of Teladoc Health during the 2nd quarter worth $27,000. Westside Investment Management Inc. purchased a new stake in shares of Teladoc Health during the 2nd quarter worth $26,000. CNB Bank lifted its position in shares of Teladoc Health by 100.0% during the 3rd quarter. CNB Bank now owns 400 shares of the health services provider’s stock worth $27,000 after purchasing an additional 200 shares during the last quarter. Finally, Capital Investment Advisory Services LLC lifted its position in shares of Teladoc Health by 800.0% during the 3rd quarter. Capital Investment Advisory Services LLC now owns 450 shares of the health services provider’s stock worth $30,000 after purchasing an additional 400 shares during the last quarter.

Shares of NYSE:TDOC opened at $80.66 on Friday. The company’s fifty day moving average price is $70.47 and its 200 day moving average price is $64.55. Teladoc Health Inc has a 12 month low of $42.08 and a 12 month high of $82.86. The company has a debt-to-equity ratio of 0.44, a current ratio of 6.55 and a quick ratio of 6.55. The firm has a market capitalization of $5.69 billion, a P/E ratio of -56.01 and a beta of 1.39.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.28) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.40) by $0.12. Teladoc Health had a negative net margin of 20.15% and a negative return on equity of 11.23%. The firm had revenue of $137.96 million for the quarter, compared to analyst estimates of $136.46 million. During the same period last year, the business earned ($0.34) EPS. Teladoc Health’s revenue for the quarter was up 24.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Teladoc Health Inc will post -1.43 EPS for the current year.

Several equities research analysts have recently issued reports on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Teladoc Health from $82.00 to $83.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Craig Hallum lifted their price target on shares of Teladoc Health from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. Deutsche Bank started coverage on shares of Teladoc Health in a research note on Thursday, September 12th. They set a “buy” rating and a $76.00 price target on the stock. ValuEngine upgraded shares of Teladoc Health from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, October 22nd. Finally, Oppenheimer set a $83.00 price target on shares of Teladoc Health and gave the stock a “buy” rating in a research note on Friday, September 6th. Three investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $77.43.

In other Teladoc Health news, insider Adam C. Vandervoort sold 50,955 shares of Teladoc Health stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $75.00, for a total value of $3,821,625.00. Following the transaction, the insider now directly owns 9,769 shares in the company, valued at $732,675. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Andrew Turitz sold 9,158 shares of Teladoc Health stock in a transaction on Monday, September 9th. The shares were sold at an average price of $62.27, for a total transaction of $570,268.66. Following the completion of the transaction, the senior vice president now owns 6,827 shares in the company, valued at $425,117.29. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 73,057 shares of company stock worth $5,336,085. 3.95% of the stock is currently owned by company insiders.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

See Also: Index Funds

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.